Josh Kaufman


My clients turn to me as a trusted advisor in critical financing and corporate transactions.

+1 212 479 6495

Josh Kaufman's practice focuses on capital markets transactions, primarily in the technology and life sciences verticals. He represents US and foreign private issuers, investment banks and institutional investors in a wide variety of securities transactions, including public offerings and private placements of common and preferred stock, investment grade and high-yield debt and convertible securities, and tender offers and consent solicitations. Josh has advised clients on more than 150 financing transactions with an aggregate value in excess of $100 billion. He also counsels clients with respect to securities law filings and compliance; general corporate and commercial matters; emerging company formation, financing and development; mergers and acquisitions; and interactions with security holders, stock exchanges and other regulatory bodies.

Download full bio


  • PolyPid – $69 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • Bavarian Nordic - DKK$2.7 Billion Rights Issue 

  • Shake Shack - $215 Combined Secondary Offerings 

  • Fangdd $78 Million – IPO 

  • View all


  • Columbia University School of Law
    JD, 2002

  • Columbia University Graduate School of Business
    MBA, 2002

  • Harvard University
    AB, 1998

Admissions & Credentials

New York


+1 212 479 6495 office
+1 347 438 3009 fax

55 Hudson Yards
New York, NY 10001-2157